Laboratory Corporation of America® Holdings (NYSE: LH) today announced
the successful completion of the previously announced subsequent
offering period for the cash tender offer by its wholly owned ... read more
Laboratory Corporation of America® Holdings (NYSE: LH) today
announced that it has reached an agreement with the U.S. Federal Trade
Commission allowing LabCorp to complete its acquisition of ... read more
Laboratory Corporation of America® Holdings (NYSE: LH) today announced
that LabCorp is extending until 5:00 p.m., New York City time, on
November 4, 2011 LabCorp’s previously announced cash ... read more
Laboratory Corporation of America® Holdings (LabCorp®)
(NYSE: LH) announced today that its Zero Coupon Convertible Subordinated
Notes due 2021 (Zero Coupon Notes) may be converted as set forth ... read more
Laboratory Corporation of America® Holdings (LabCorp®)
(NYSE: LH) announced today the nationwide availability of a new
FDA-approved companion diagnostic for lung cancer patients.
... read more
Laboratory Corporation of America® Holdings (LabCorp®)
(NYSE: LH) announced today that for the period of September 12, 2011 to
March 11, 2012, its Zero Coupon Convertible Subordinated Notes ... read more